An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

Miss America Madison Marsh and Julie Flessman of the Pancreatic Cancer Action Network joined Fox 5 to talk about the disease ...

Type 1 diabetes mellitus (T1DM) is an autoimmune disease where the immune system attacks insulin-beta cells in the pancreas, leading to high blood sugar resulting from insulin deficiency. Unlike type ...

Approximately 1 in 56 men and 1 in 60 women will be diagnosed with pancreatic cancer at some point in their lives, and Pennsylvania has slightly higher rates ...

New classes of drugs like the SGLT-2 Inhibitors and GLP-1 Receptor Agonists  have tremendous potential for managing the blood ...

On World Diabetes Day, we talk to experts about the causes, symptoms and treatment of type 1 and 2 diabetes, and changes that ...

In the 21st century it is difficult to imagine that you might read statistics like the ones below in relation to cancer. “Surgery is the only treatment with curative intent for people with this cancer ...

The Gibraltar Pancreatic Cancer Charity’s second annual ‘Purple Relay’ saw four runners deliver batons with messages of ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

This review explores the role of lysosomal stress in pancreatic diseases, particularly diabetes mellitus. Lysosomes, crucial ...